Both in Pharmaceuticals
Foghorn Therapeutics vs Anixa Biosciences
Over the past year FHTX returned −53.0% and ANIX returned −21.7%; their daily moves had a correlation of 0.19.
FHTX −53.0% ANIX −21.7%Growth of $1, one year, split-adjusted
| Metric | FHTX | ANIX |
|---|---|---|
| Price | $2.09 | $3.32 |
| Market cap | $124.1M | $115.4M |
| Today | −1.88% | −1.48% |
| 1 month | −41.5% | +13.3% |
| 6 months | −56.0% | +10.7% |
| Year to date | −61.3% | +6.4% |
| 1 year | −53.0% | −21.7% |
| Revenue growth (YoY) | +112.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | — |
| Net cash | $167.6M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 105.7% | 57.7% |
| Short % of float | 7.3% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).